CLRA 510 Introduction to Drug Development

Introduction to the pharmaceutical industry and the process of drug discovery and development. Drug development phases 1-4 are reviewed. Regulatory requirements of the Food and Drug Administration are introduced, including the investigational new drug application (IND) and the new drug application (NDA). The roles of investigator, coordinator, sponsor, and monitor are discussed.

Credit 3 hrs May not be repeated for additional credit
Grade Mode Normal (A-F) Course Rotation Fall (in-person)

Prerequisites -
Corequisites - CLRA 520
Restriction by Major -
Restriction by Degree Type - Graduate standing

Equivalent Course(s) -
Course History -
Change to description 2/2024, effective Fall 2024; Course Rotation added 9/2014

Winter 2025 Course Sections

Fall 2024 Course Sections